On June 4th, the U.S. FDA’s panel of independent advisers will convene to discuss the potential approval of the first MDMA-assisted therapy for post-traumatic stress
NEW YORK–(BUSINESS WIRE)– Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain
Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and
MELBOURNE, Australia and NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company, is pleased
VANCOUVER, BC, May 7, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based
Since March, when the first reported cases of H5N1 bird flu began showing up in dairy cattle in Texas, the Food and Drug Administration has
In the latest bid to widen access to medicines, a nonprofit is sending technology and materials for making expensive CAR-T cell therapies to the Brazilian
Yes, it’s possible to have a worm living in your brain — in fact, it’s far more common than you might think, said Dr. David
What You Should Know: – Ciba Health, a cutting-edge digital health company simplifying healthcare with a personalized, whole person-care approach to prevent and reverse chronic
What You Should Know: – Geisinger Health Plan (GHP) with OncoHealth®, the leading platform for managing the cost and complexity of cancer, will provide supportive